LTGO
Latigo Biotherapeutics, Inc.
15.90$
-4.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 26 | Q2 26 |
|---|---|---|
| 100.0% | 100.0% | |
| 92.6% | 91.4% | |
| 83.4% | 84.9% | |
| 599.4% | 526.3% | |
| 28.6% | 79.6% | |
| 8.8% | 5.5% | |
| -499.4% | -426.3% | |
| -526.1% | -450.7% | |
| 118.9% | 92.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.